Shanghai MicroPort Endovascular MedTech Co., Ltd. (688016.SS)
CNY 113.48
(-0.65%)
CNY 113.48
(-0.65%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 895.59 Million CNY | 30.67% |
| 2022 | 673.98 Million CNY | 26.13% |
| 2021 | 534.34 Million CNY | 43.65% |
| 2020 | 371.97 Million CNY | 40.47% |
| 2019 | 264.8 Million CNY | 45.37% |
| 2018 | 182.16 Million CNY | 41.92% |
| 2017 | 128.35 Million CNY | 34.14% |
| 2016 | 95.68 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 319.93 Million CNY | 18.35% |
| 2024 Q1 | 270.32 Million CNY | 24.18% |
| 2024 Q3 | 128.73 Million CNY | -59.76% |
| 2023 Q4 | 217.69 Million CNY | 6.92% |
| 2023 Q3 | 203.6 Million CNY | -22.58% |
| 2023 Q2 | 262.97 Million CNY | 21.59% |
| 2023 FY | 880.72 Million CNY | 30.67% |
| 2023 Q1 | 216.28 Million CNY | 25.92% |
| 2022 Q2 | 147.98 Million CNY | -26.26% |
| 2022 Q1 | 200.67 Million CNY | 53.76% |
| 2022 Q3 | 153.55 Million CNY | 3.76% |
| 2022 FY | 673.98 Million CNY | 26.13% |
| 2022 Q4 | 171.77 Million CNY | 11.87% |
| 2021 Q3 | 115.46 Million CNY | -11.37% |
| 2021 Q4 | 130.51 Million CNY | 13.04% |
| 2021 FY | 534.34 Million CNY | 43.65% |
| 2021 Q2 | 130.26 Million CNY | -17.61% |
| 2021 Q1 | 158.1 Million CNY | 40.74% |
| 2020 Q2 | 92.18 Million CNY | 17.34% |
| 2020 Q1 | 78.56 Million CNY | 14.26% |
| 2020 FY | 371.97 Million CNY | 40.47% |
| 2020 Q4 | 112.34 Million CNY | 26.39% |
| 2020 Q3 | 88.88 Million CNY | -3.58% |
| 2019 Q3 | 59.45 Million CNY | -6.71% |
| 2019 Q2 | 63.73 Million CNY | -12.51% |
| 2019 Q1 | 72.84 Million CNY | 63.57% |
| 2019 FY | 264.8 Million CNY | 45.37% |
| 2019 Q4 | 68.75 Million CNY | 15.64% |
| 2018 Q1 | 66.53 Million CNY | 0.0% |
| 2018 FY | 182.16 Million CNY | 41.92% |
| 2018 Q4 | 44.53 Million CNY | 12.99% |
| 2018 Q3 | 39.41 Million CNY | 24.44% |
| 2018 Q2 | 31.67 Million CNY | -52.4% |
| 2017 FY | 128.35 Million CNY | 34.14% |
| 2016 FY | 95.68 Million CNY | 0.0% |